Alshimary, N.A.A.H. and Tweij, T.-A.R. 2025. Praliciguat alleviates ferroptosis and inflammation in renal ischemia/reperfusion injury by targeting the AMPK/ACC/PUFA pathway. Babcock University Medical Journal. 8, 2 (Dec. 2025), 198–207. DOI:https://doi.org/10.38029/babcockuniv.med.j. v8i2.992.